These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Serological investigation of asymptomatic cases of SARS-CoV-2 infection reveals weak and declining antibody responses. Yang Y; Wang X; Du RH; Zhang W; Si HR; Zhu Y; Shen XR; Li Q; Li B; Men D; Zhou YN; Wang H; Tong XL; Zhang XE; Shi ZL; Zhou P Emerg Microbes Infect; 2021 Dec; 10(1):905-912. PubMed ID: 33870851 [TBL] [Abstract][Full Text] [Related]
65. Prevalence of SARS-CoV-2 IgG antibodies in an area of northeastern Italy with a high incidence of COVID-19 cases: a population-based study. Stefanelli P; Bella A; Fedele G; Pancheri S; Leone P; Vacca P; Neri A; Carannante A; Fazio C; Benedetti E; Fiore S; Fabiani C; Simmaco M; Santino I; Zuccali MG; Bizzarri G; Magnoni R; Benetollo PP; Merler S; Brusaferro S; Rezza G; Ferro A Clin Microbiol Infect; 2021 Apr; 27(4):633.e1-633.e7. PubMed ID: 33253941 [TBL] [Abstract][Full Text] [Related]
68. Seroprevalence of Antibodies Specific to Receptor Binding Domain of SARS-CoV-2 and Vaccination Coverage Among Adults in Los Angeles County, April 2021: The LA Pandemic Surveillance Cohort Study. Sood N; Pernet O; Lam CN; Klipp A; Kotha R; Kovacs A; Hu H JAMA Netw Open; 2022 Jan; 5(1):e2144258. PubMed ID: 35050360 [TBL] [Abstract][Full Text] [Related]
69. Seroprevalence of anti-SARS-CoV-2 antibodies and factors associated with infection among adolescent men who have sex with men and transgender women in Salvador, Brazil. Santos CC; de M Lima FW; Magno L; Soares F; Ferraz D; Grangeiro A; Zucchi EM; Préau M; Mabire X; Matos HRSS; Dourado I; BMC Public Health; 2023 Jan; 23(1):61. PubMed ID: 36624484 [TBL] [Abstract][Full Text] [Related]
70. Sentinel seroprevalence of SARS-CoV-2 in Gauteng Province, South Africa, August - October 2020. George JA; Khoza S; Mayne E; Dlamini S; Kone N; Jassat W; Chetty K; Centner CM; Pillay T; Maphayi M; Mabuza D; Maposa I; Cassim N S Afr Med J; 2021 Nov; 111(11):1078-1083. PubMed ID: 34949273 [TBL] [Abstract][Full Text] [Related]
71. Seroprevalence and levels of IgG antibodies after COVID-19 infection or vaccination. Soeorg H; Jõgi P; Naaber P; Ottas A; Toompere K; Lutsar I Infect Dis (Lond); 2022 Jan; 54(1):63-71. PubMed ID: 34520315 [TBL] [Abstract][Full Text] [Related]
72. SARS-CoV-2 seroprevalence in the city of Puerto Madryn: Underdiagnosis and relevance of children in the pandemic. Schonfeld D; Fernández H; Ramírez J; Acosta D; Becerra J; Wettstein M; Strella T; Vaccaro M; Arias S; Rodríguez Calvo V; Neme R; Pérez-Chada D PLoS One; 2022; 17(3):e0263679. PubMed ID: 35286328 [TBL] [Abstract][Full Text] [Related]
73. Seroprevalence of anti-SARS-CoV-2 antibodies after the first wave of the COVID-19 pandemic in a vulnerable population in France: a cross-sectional study. Beaumont A; Durand C; Ledrans M; Schwoebel V; Noel H; Le Strat Y; Diulius D; Colombain L; Médus M; Gueudet P; Mouly D; Aumaître H BMJ Open; 2021 Nov; 11(11):e053201. PubMed ID: 34815286 [TBL] [Abstract][Full Text] [Related]
74. Seroprevalence Surveys for Anti-SARS-CoV-2 Antibody in Different Populations in Taiwan With Low Incidence of COVID-19 in 2020 and Severe Outbreaks of SARS in 2003. Tseng WP; Wu JL; Wu CC; Kuo KT; Lin CH; Chung MY; Lee YF; Yang BJ; Huang CH; Chen SY; Yu CJ; Chen SC; Hsueh PR Front Immunol; 2021; 12():626609. PubMed ID: 34084161 [TBL] [Abstract][Full Text] [Related]
75. Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic. Anand S; Montez-Rath M; Han J; Cadden L; Hunsader P; Kerschmann R; Beyer P; Boyd SD; Garcia P; Dittrich M; Block GA; Parsonnet J; Chertow GM JAMA Netw Open; 2021 Jul; 4(7):e2116572. PubMed ID: 34251441 [TBL] [Abstract][Full Text] [Related]
76. Community-Based Seroprevalence of SARS-CoV-2 Antibodies following the First Wave of the COVID-19 Pandemic in Jazan Province, Saudi Arabia. Alhazmi A; Alamer E; Abdelwahab S; Khamjan N; Hamami A; Haddad M; Darraj M; Hashem AM; Algaissi A Int J Environ Res Public Health; 2021 Nov; 18(23):. PubMed ID: 34886175 [TBL] [Abstract][Full Text] [Related]
77. Seroprevalence of SARS-CoV-2-specific antibodies in cancer outpatients in Madrid (Spain): A single center, prospective, cohort study and a review of available data. Cabezón-Gutiérrez L; Custodio-Cabello S; Palka-Kotlowska M; Oliveros-Acebes E; García-Navarro MJ; Khosravi-Shahi P Cancer Treat Rev; 2020 Nov; 90():102102. PubMed ID: 32947121 [TBL] [Abstract][Full Text] [Related]
78. Seroprevalence and factors associated with SARS-CoV-2 infection among education workers after the first wave: the first cross-sectional study in Brazil. França PC; Silva PGB; Rocha JLC; Perdigão ACB; Oliveira NS; Araújo FMC; Fonseca MHG; Lima GRP; Almeida MM; Alencar CH; Oliveira WK; Cavalcanti LPG Rev Soc Bras Med Trop; 2022; 55():e06062021. PubMed ID: 35522813 [TBL] [Abstract][Full Text] [Related]
79. Seroprevalence of SARS-CoV-2-Specific IgG Antibodies Among Adults Living in Connecticut: Post-Infection Prevalence (PIP) Study. Mahajan S; Srinivasan R; Redlich CA; Huston SK; Anastasio KM; Cashman L; Massey DS; Dugan A; Witters D; Marlar J; Li SX; Lin Z; Hodge D; Chattopadhyay M; Adams MD; Lee C; Rao LV; Stewart C; Kuppusamy K; Ko AI; Krumholz HM Am J Med; 2021 Apr; 134(4):526-534.e11. PubMed ID: 33130124 [TBL] [Abstract][Full Text] [Related]
80. A cross-sectional investigation of SARS-CoV-2 seroprevalence and associated risk factors in children and adolescents in the United States. Levorson RE; Christian E; Hunter B; Sayal J; Sun J; Bruce SA; Garofalo S; Southerland M; Ho S; Levy S; Defillipi C; Peake L; Place FC; Hourigan SK PLoS One; 2021; 16(11):e0259823. PubMed ID: 34748615 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]